v3.26.1
Shareholders' Equity - (Details) - USD ($)
$ in Thousands
 3 Months Ended 68 Months Ended
Jul. 11, 2025
Mar. 18, 2025
Jul. 29, 2020
Mar. 31, 2026
Mar. 31, 2026
Dec. 31, 2025
Authorized share capital            
Issuance of common shares, net of issuance costs (in shares) 31,500,000          
Proceeds from issuance or sale of equity $ 48,600   $ 50,000      
Issuance of common shares, net of issuance costs       $ 10,891    
Proceeds from issuance of common shares, net of issuance costs       $ 10,890    
Stock issuance cost $ 3,900          
Warrants outstanding       16,412,925 16,412,925 16,412,925
ATM Program            
Authorized share capital            
Issuance of common shares, net of issuance costs (in shares)       5,526,590    
Issuance of common shares, net of issuance costs         $ 2,800  
Proceeds from issuance of common shares, net of issuance costs       $ 10,900    
Stock issuance cost       300    
ATM Program | Maximum            
Authorized share capital            
Issuance of common shares, net of issuance costs   $ 77,800        
Series A common warrants            
Authorized share capital            
Proceeds from exercise of warrants, net of issuance costs       $ 8,000    
Exercise of Series A common stock warrants, net of issuance costs (in shares)       5,666,666    
Underwriting commissions       $ 500    
Warrants outstanding       15,705,662 15,705,662  
Series B common warrants            
Authorized share capital            
Warrants outstanding       34,335,669 34,335,669